Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GSK3A | P49840 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9962913 | 0.81 | NPC1 (0.33) | ALDH1A1POLBMAPTCA12CA9 | |
| SCHEMBL6227212 | 0.77 | GSK3B (0.46) | ALDH1A1KDM4EMAPTCA12MEN1 | |
| SCHEMBL11504046 | 0.76 | AKR1B1 (0.50) | AKR1B1ALDH1A1KDM4EPOLBMAPT | |
| SCHEMBL11504096 | 0.74 | AKR1B1 (0.39) | AKR1B1ALDH1A1KDM4EPOLBMAPT | |
| SCHEMBL11503692 | 0.74 | AKR1B1 (0.39) | AKR1B1ALDH1A1KDM4EPOLBMAPT | |
| SCHEMBL3189599 | 0.74 | GRIN2D (0.40) | AKR1B1ALDH1A1KDM4EPOLBMAPT | |
| SCHEMBL9734939 | 0.68 | AKR1B1 (0.50) | AKR1B1ALDH1A1KDM4EPOLBMAPT | |
| SCHEMBL11504866 | 0.68 | L3MBTL1 (0.38) | AKR1B1L3MBTL1 | |
| SCHEMBL11503884 | 0.68 | AKR1B1 (0.35) | AKR1B1ALDH1A1KDM4EPOLBMAPT | |
| SCHEMBL11503924 | 0.68 | AKR1B1 (0.35) | AKR1B1ALDH1A1KDM4EPOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 338 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1547096-B1 | MULTIPLE HAZARD PROTECTION ARTICLES AND METHODS FOR MAKING THEM | MERIDIAN RES AND DEVELOPMENT (US) | 2018-04-11 | — | — | EP | claimed |
| CN-103841848-B | Radioprotector and its method | 施特姆拉德有限公司 | 2017-12-05 | — | — | CN | claimed |
| CN-103841848-A | Radiation protection device and methods thereof | STEMRAD LTD | 2014-06-04 | — | — | CN | claimed |
| US-20130225640-A1 | CYANOACRYLATE-BASED BIO-ADHESIVE COMPOSITION | INTUITIVE MEDI CORP INC. (KR) | 2013-08-29 | — | — | US | claimed |
| US-8501242-B2 | Methods and compositions for treating neoplasia | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) | 2013-08-06 | — | — | US | claimed |
| US-20120156212-A1 | METHODS AND COMPOSITIONS FOR TREATING NEOPLASIA | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION | 2012-06-21 | — | — | US | claimed |
| CN-1689120-B | Multiple hazard prevention article and method of making same | MERIDIAN RES & DEV | 2012-05-09 | — | — | CN | claimed |
| CN-101945672-A | Biodegradable contrast agents | IOPHARMA TECHNOLOGIES AB | 2011-01-12 | — | — | CN | claimed |
| US-7588751-B2 | Liposome-containing radiographic contrast medium and preparation method thereof | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-09-15 | — | — | US | claimed |
| US-7109377-B2 | Synthesis of combinatorial libraries of compounds reminiscent of natural products | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2006-09-19 | — | — | US | claimed |
| CN-1689120-A | Multiple hazard prevention article and method of making same | MERIDIAN RES & DEV (US) | 2005-10-26 | — | — | CN | claimed |
| EP-0797442-B1 | TREATMENT OF OPTIC NEURITIS | MASSACHUSETTS EYE & EAR INFIRM (US) | 2003-05-21 | — | — | EP | claimed |
| US-20030082830-A1 | Synthesis of combinatorial libraries of compounds reminiscent of natural products | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-05-01 | — | — | US | claimed |
| US-6465174-B1 | EXPOSURE OF LIGHT SENSITIVE FLUID CONTAINING METHYLENE BLUE, N,N,N*,N*-TETRAMETHYLETHYLENEDIAMINE, AND ACRYLAMIDE TO LIGHT PATTERN CAUSING COALESCENCE AND ADHESION | UNIVERSITY OF CHICAGO | 2002-10-15 | — | — | US | claimed |
| US-6448443-B1 | GENERATED FROM DIVERSIFIABLE SCAFFOLDS SYNTHESIZED FROM THE PYRIDINE-BASED TEMPLATE ISONICOTINAMIDE; ALSO PROVIDES A NOVEL ORTHO-NITROBENZYL PHOTOLINKER; SYNTHESIZED FROM A SHIKIMIC ACID BASED EPOXYOL TEMPLATE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2002-09-10 | — | — | US | claimed |
| WO-2000006525-A2 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-02-10 | — | — | WO | claimed |
| EP-0070198-B1 | RADIATION-SENSITIVE COMPOSITION AND PATTERN-FORMATION METHOD USING THE SAME | Hitachi, Ltd. (JP) | 1985-06-19 | — | — | EP | claimed |
| EP-0050457-A1 | Radiopaque cyanoacrylate compositions | BioNexus, Inc. (US) | 1982-04-28 | — | — | EP | claimed |
| US-4192859-A | MEDICAL DIAGNOSIS USING X-RAYS | E. R. SQUIBB & SONS, INC. (US) | 1980-03-11 | — | — | US | claimed |
| EP-4706684-A2 | COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES | The Regents of The University of Michigan (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4706683-A2 | CHEWABLE FORMULATIONS | Elanco Tiergesundheit AG (CH) | 2026-03-11 | — | — | EP | disclosed |
| EP-4034253-B1 | COMPOSITIONS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES | UNIV MICHIGAN REGENTS (US) | 2026-01-21 | — | — | EP | disclosed |
| US-20250367178-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | AVALYN PHARMA INC (US) | 2025-12-04 | — | — | US | disclosed |
| EP-4656211-A2 | COMPOSITIONS FOR EMBOLIZATION | Iberhospitex, S.A. (ES) | 2025-12-03 | — | — | EP | disclosed |
| EP-4376905-B1 | COMPOSITIONS FOR EMBOLIZATION | IBERHOSPITEX SA (ES) | 2025-10-22 | — | — | EP | disclosed |
| WO-2025217094-A1 | INTERLEUKIN RECEPTOR-ASSOCIATED KINASE (IRAK) PROTAC DEGRADERS AND MEDICAL USE THEREOF | UNIVERSITY OF ROCHESTER (US) | 2025-10-16 | — | — | WO | disclosed |
| US-20250320190-A1 | Novel Inhibitors of Leucine Carboxyl Methyltransferase-1 (LCMT-1) and Methods of Use Thereof | UNIV TEMPLE (US) | 2025-10-16 | — | — | US | disclosed |
| WO-2025217096-A1 | INHIBITORS OF LEUCINE-RICH REPEAT KINASE 2 (LRRK2) AND MEDICAL USES THEREOF | UNIVERSITY OF ROCHESTER (US) | 2025-10-16 | — | — | WO | disclosed |
| EP-4604947-A2 | COMPOSITIONS AND METHODS FOR PREVENTING CARDIOMYOPATHY | Ohio State Innovation Foundation (US) | 2025-08-27 | — | — | EP | disclosed |
| US-20250255780-A1 | SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVES | AQUESTIVE THERAPEUTICS, INC. (US) | 2025-08-14 | — | — | US | disclosed |
| US-20250114376-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | AVALYN PHARMA INC. | 2025-04-10 | — | — | US | disclosed |
| US-20250058078-A1 | DIAGNOSTIC CATHETERS, GUIDE CATHETERS, VISUALIZATION DEVICES AND CHORD MANIPULATION DEVICES, AND RELATED KITS AND METHODS | ANCORA HEART, INC. | 2025-02-20 | — | — | US | disclosed |
| US-12226407-B2 | Aerosol pirfenidone and pyridone analog compounds and uses thereof | AVALYN PHARMA INC. (US) | 2025-02-18 | — | — | US | disclosed |
| EP-4491180-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | Avalyn Pharma Inc. (US) | 2025-01-15 | — | — | EP | disclosed |
| US-12171723-B2 | System and method for making personalized individual unit doses containing pharmaceutical actives | AQUESTIVE THERAPEUTICS, INC. (US) | 2024-12-24 | — | — | US | disclosed |
| US-20240358885-A1 | COMPOSITIONS FOR EMBOLIZATION | IBERHOSPITEX, S.A. (ES) | 2024-10-31 | — | — | US | disclosed |
| US-20240299299-A1 | COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-09-12 | — | — | US | disclosed |
| US-20240261447-A1 | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO THE HEPATOPANCREATIC ANATOMICAL REGION | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-08-08 | — | — | US | disclosed |
| EP-3091976-B1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | AVALYN PHARMA INC (US) | 2024-07-24 | — | — | EP | disclosed |
| US-12023342-B2 | Aerosol pirfenidone and pyridone analog compounds and uses thereof | AVALYN PHARMA INC. (US) | 2024-07-02 | — | — | US | disclosed |
| EP-4376905-A1 | COMPOSITIONS FOR EMBOLIZATION | Iberhospitex, S.A. (ES) | 2024-06-05 | — | — | EP | disclosed |
| US-11980722-B2 | Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods | ANCORA HEART, INC. (US) | 2024-05-14 | — | — | US | disclosed |
| EP-4359004-A1 | COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES | The Regents Of The University Of Michigan (US) | 2024-05-01 | — | — | EP | disclosed |
| WO-2024086708-A2 | COMPOSITIONS AND METHODS FOR PREVENTING CARDIOMYOPATHY | OHIO STATE INNOVATION FOUNDATION (US) | 2024-04-25 | — | — | WO | disclosed |
| CN-117897179-A | Composition for embolization | 伊伯霍斯皮特克斯公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20240074995-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FIRST WAVE BIO, INC. | 2024-03-07 | — | — | US | disclosed |
| US-20240050317-A1 | SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVES | AQUESTIVE THERAPEUTICS, INC. (US) | 2024-02-15 | — | — | US | disclosed |
| US-11793777-B2 | Methods and compositions for treating conditions associated with an abnormal inflammatory response | FIRST WAVE BIO, INC. (US) | 2023-10-24 | — | — | US | disclosed |
| US-20230295146-A1 | INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES 1 AND 4 | THE UNIVERSITY OF ROCHESTER | 2023-09-21 | — | — | US | disclosed |
| US-11744812-B2 | Methods of treatment | FIRST WAVE BIO, INC. (US) | 2023-09-05 | — | — | US | disclosed |
| CN-111662228-B | Pyridone acyl biarylamine compounds and uses thereof | 中国医学科学院药物研究所 | 2023-07-28 | — | — | CN | disclosed |
| WO-2023118074-A1 | COMPRESSIBLE AND FREE FLOWING CO-PROCESSED MESOPOROUS SILICA | UNIVERZA V LJUBLJANI (SI) | 2023-06-29 | — | — | WO | disclosed |
| US-20230201143-A1 | METHODS OF TREATMENT | FIRST WAVE BIO, INC. | 2023-06-29 | — | — | US | disclosed |
| US-20230190684-A1 | METHODS OF TREATING COVID-19 WITH A NICLOSAMIDE COMPOUND | FIRST WAVE BIO, INC. | 2023-06-22 | — | — | US | disclosed |
| EP-4185568-A1 | INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES 1 AND 4 | The University of Rochester (US) | 2023-05-31 | — | — | EP | disclosed |
| US-20230159586-A1 | INHIBITORS OF HUMAN EPIDIDYMUS PROTEIN 4 | UNIVERSITY OF ROCHESTER | 2023-05-25 | — | — | US | disclosed |
| US-20230149375-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | AVALYN PHARMA INC. | 2023-05-18 | — | — | US | disclosed |
| US-20230102999-A1 | DEUTERATED NICLOSAMIDE | FIRST WAVE BIO, INC. | 2023-03-30 | — | — | US | disclosed |
| US-11605473-B1 | Material for reducing exposure to ionizing radiation | Iron Knight Aviation, LLC (US) | 2023-03-14 | — | — | US | disclosed |
| EP-4139289-A1 | INHIBITORS OF HUMAN EPIDIDYMUS PROTEIN 4 | University of Rochester (US) | 2023-03-01 | — | — | EP | disclosed |
| WO-2023009424-A1 | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO THE HEPATOPANCREATIC ANATOMICAL REGION | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2023-02-02 | — | — | WO | disclosed |
| WO-2023006679-A1 | COMPOSITIONS FOR EMBOLIZATION | IBERHOSPITEX, S.A. (ES) | 2023-02-02 | — | — | WO | disclosed |
| US-11564896-B2 | Methods of treatment | FIRST WAVE BIO, INC. (US) | 2023-01-31 | — | — | US | disclosed |
| US-11559520-B2 | Aerosol pirfenidone and pyridone analog compounds and uses thereof | AVALYN PHARMA INC. (US) | 2023-01-24 | — | — | US | disclosed |
| US-11541002-B2 | Oral film compositions and dosage forms having precise active dissolution profiles | AQUESTIVE THERAPEUTICS, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| WO-2022271822-A1 | COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2022-12-29 | — | — | WO | disclosed |
| US-20220347294-A1 | COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2022-11-03 | — | — | US | disclosed |
| US-11452718-B2 | Aerosol pirfenidone and pyridone analog compounds and uses thereof | AVALYN PHARMA INC. (US) | 2022-09-27 | — | — | US | disclosed |
| EP-4059499-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | Avalyn Pharma Inc. (US) | 2022-09-21 | — | — | EP | disclosed |
| EP-4058029-A1 | MULTIMODAL COMPOSITIONS AND METHODS OF TREATMENT | Aquestive Therapeutics, Inc. (US) | 2022-09-21 | — | — | EP | disclosed |
| EP-4051235-A1 | PRODRUG COMPOSITIONS AND METHODS OF TREATMENT | Aquestive Therapeutics, Inc. (US) | 2022-09-07 | — | — | EP | disclosed |
| EP-4045480-A1 | PHARMACEUTICAL FORMULATIONS | First Wave Bio, Inc. (US) | 2022-08-24 | — | — | EP | disclosed |
| EP-4034253-A1 | COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES | The Regents Of The University Of Michigan (US) | 2022-08-03 | — | — | EP | disclosed |
| US-20220218683-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | AVALYN PHARMA INC. | 2022-07-14 | — | — | US | disclosed |
| US-20220152348-A1 | DIAGNOSTIC CATHETERS, GUIDE CATHETERS, VISUALIZATION DEVICES AND CHORD MANIPULATION DEVICES, AND RELATED KITS AND METHODS | ANCORA HEART, INC. | 2022-05-19 | — | — | US | disclosed |
| US-RE49076-E1 | Compositions and methods for treating renal disease | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2022-05-17 | — | — | US | disclosed |
| US-11311538-B2 | Compositions and methods for targeting cancers | YALE UNIVERSITY (US) | 2022-04-26 | — | — | US | disclosed |
| US-20220105057-A1 | METHODS OF TREATMENT | FIRST WAVE BIO, INC. | 2022-04-07 | — | — | US | disclosed |
| US-20220079897-A1 | METHODS OF TREATMENT | FIRST WAVE BIO, INC. | 2022-03-17 | — | — | US | disclosed |
| WO-2022020661-A1 | INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES 1 AND 4 | THE UNIVERSITY OF ROCHESTER (US) | 2022-01-27 | — | — | WO | disclosed |
| US-11224592-B2 | Aerosol pirfenidone and pyridone analog compounds and uses thereof | AVALYN PHARMA INC. (US) | 2022-01-18 | — | — | US | disclosed |
| US-20220000812-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FIRST WAVE BIO, INC. | 2022-01-06 | — | — | US | disclosed |
| US-20210401784-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSE | FIRST WAVE BIO, INC. | 2021-12-30 | — | — | US | disclosed |
| US-11202883-B2 | Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods | ANCORA HEART, INC. (US) | 2021-12-21 | — | — | US | disclosed |
| US-20210346399-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | AVALYN PHARMA INC. (US) | 2021-11-11 | — | — | US | disclosed |
| WO-2021188564-A1 | METHODS OF TREATING COVID-19 WITH A NICLOSAMIDE COMPOUND | FIRST WAVE BIO, INC. (US) | 2021-09-23 | — | — | WO | disclosed |
| US-11071741-B2 | Aerosol pirfenidone and pyridone analog compound and uses thereof | AVALYN PHARMA INC. (US) | 2021-07-27 | — | — | US | disclosed |
| US-11034719-B2 | 7-dehydrocholesterol derivatives and methods using same | UNIVERSITY OF ROCHESTER (US) | 2021-06-15 | — | — | US | disclosed |
| EP-3128996-B1 | NOVEL 7-DEHYDROCHOLESTEROL DERIVATIVES AND METHODS USING SAME | UNIV ROCHESTER (US) | 2021-06-02 | — | — | EP | disclosed |
| CN-110483384-B | Preparation method of 3, 5-dihalogen-4-pyridone-1-acetic acid | 新发药业有限公司 | 2021-05-14 | — | — | CN | disclosed |
| WO-2021076922-A1 | PHARMACEUTICAL FORMULATIONS | FIRST WAVE BIO, INC. (US) | 2021-04-22 | — | — | WO | disclosed |
| US-20210114973-A1 | PHARMACEUTICAL FORMULATIONS | FIRST WAVE BIO, INC. | 2021-04-22 | — | — | US | disclosed |
| US-10980756-B1 | Methods of treatment | FIRST WAVE BIO, INC. (US) | 2021-04-20 | — | — | US | disclosed |
| US-20210069165-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | AVALYN PHARMA INC. (US) | 2021-03-11 | — | — | US | disclosed |
| US-10912746-B2 | Methods and compositions for treating conditions associated with an abnormal inflammatory response | FIRST WAVE BIO, INC. (US) | 2021-02-09 | — | — | US | disclosed |
| US-10905666-B2 | Methods and compositions for treating conditions associated with an abnormal inflammatory response | FIRST WAVE BIO, INC. (US) | 2021-02-02 | — | — | US | disclosed |
| US-20200405704-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | AVALYN PHARMA INC. (US) | 2020-12-31 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-10849867-B2 | Methods and compositions for treating conditions associated with an abnormal inflammatory response | FIRST WAVE BIO, INC. (US) | 2020-12-01 | — | — | US | disclosed |
| US-10799468-B2 | Methods and compositions for treating conditions associated with an abnormal inflammatory responses | FIRST WAVE BIO, INC. (US) | 2020-10-13 | — | — | US | disclosed |
| US-20200306264-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUND AND USES THEREOF | AVALYN PHARMA INC. (US) | 2020-10-01 | — | — | US | disclosed |
| US-20200291060-A1 | NOVEL 7-DEHYDROCHOLESTEROL DERIVATIVES AND METHODS USING SAME | WOMEN & INFANTS HOSPITAL OF RHODE ISLAND | 2020-09-17 | — | — | US | disclosed |
| US-10772854-B2 | Methods and compositions for treating conditions associated with an abnormal inflammatory response | FIRST WAVE BIO, INC. (US) | 2020-09-15 | — | — | US | disclosed |
| CN-111662228-A | Pyridone acyl biaryl amine compound and application thereof | 中国医学科学院药物研究所 | 2020-09-15 | — | — | CN | disclosed |
| US-20200276140-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FIRST WAVE BIO, INC. | 2020-09-03 | — | — | US | disclosed |
| US-20200268694-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FIRST WAVE BIO, INC. | 2020-08-27 | — | — | US | disclosed |
| US-10744103-B2 | Methods and compositions for treating conditions associated with an abnormal inflammatory responses | FIRST WAVE BIO, INC. (US) | 2020-08-18 | — | — | US | disclosed |
| US-20200197340-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FIRST WAVE BIO, INC. | 2020-06-25 | — | — | US | disclosed |
| US-20200197339-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FIRST WAVE BIO, INC. | 2020-06-25 | — | — | US | disclosed |
| US-10683324-B2 | 7-dehydrocholesterol derivatives and methods using same | UNIVERSITY OF ROCHESTER (US) | 2020-06-16 | — | — | US | disclosed |
| US-20200147012-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FIRST WAVE BIO, INC. | 2020-05-14 | — | — | US | disclosed |
| US-20200147343-A1 | DIAGNOSTIC CATHETERS, GUIDE CATHETERS, VISUALIZATION DEVICES AND CHORD MANIPULATION DEVICES, AND RELATED KITS AND METHODS | GUIDED DELIVERY SYSTEMS INC. | 2020-05-14 | — | — | US | disclosed |
| US-20200147013-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FIRST WAVE BIO, INC. | 2020-05-14 | — | — | US | disclosed |
| US-10625046-B2 | Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods | ANCORA HEART, INC. (US) | 2020-04-21 | — | — | US | disclosed |
| US-10610536-B2 | Aerosol pirfenidone and pyridone analog compounds and uses thereof | AVALYN PHARMA INC. (US) | 2020-04-07 | — | — | US | disclosed |
| US-20190298670-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | MONTERESEARCH S.R.L. (IT) | 2019-10-03 | — | — | US | disclosed |
| US-10292951-B2 | Methods and compositions for treating conditions associated with an abnormal inflammatory responses | FIRST WAVE BIO, INC. (US) | 2019-05-21 | — | — | US | disclosed |
| US-20190133980-A1 | Compositions and methods for targeting and treating homologous recombination-deficient tumors | UNIV YALE (US) | 2019-05-09 | — | — | US | disclosed |
| US-20190054076-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | AVALYN PHARMA INC. (US) | 2019-02-21 | — | — | US | disclosed |
| US-20190030012-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | AVALYN PHARMA INC. (US) | 2019-01-31 | — | — | US | disclosed |
| US-20180325917-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | AVALYN PHARMA INC. (US) | 2018-11-15 | — | — | US | disclosed |
| US-10105356-B2 | Aerosol pirfenidone and pyridone analog compounds and uses thereof | AVALYN PHARMA INC. (US) | 2018-10-23 | — | — | US | disclosed |
| US-10092552-B2 | Aerosol pirfenidone and pyridone analog compounds and uses thereof | AVALYN PHARMA INC. (US) | 2018-10-09 | — | — | US | disclosed |
| CN-108578790-A | One kind can developable seaweed acidic group biomaterial and preparation method thereof | 宁波迪创医疗科技有限公司 | 2018-09-28 | — | — | CN | disclosed |
| US-20180273580-A1 | NOVEL 7-DEHYDROCHOLESTEROL DERIVATIVES AND METHODS USING SAME | UNIVERSITY OF ROCHESTER | 2018-09-27 | — | — | US | disclosed |
| US-10028966-B2 | Aerosol pirfenidone and pyridone analog compounds and uses thereof | AVALYN PHARMA INC. (US) | 2018-07-24 | — | — | US | disclosed |
| EP-3344274-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | First Wave Bio, Inc. (US) | 2018-07-11 | — | — | EP | disclosed |
| US-9982010-B2 | 7-dehydrocholesterol derivatives and methods using same | WOMEN & INFANTS HOSPITAL OF RHODE ISLAND (US) | 2018-05-29 | — | — | US | disclosed |
| CN-105120908-B | The improved solidification of hardenable bone substitute | 骨支撑股份公司 | 2018-04-27 | — | — | CN | disclosed |
| WO-2017210608-A1 | COMPOSITIONS AND METHODS FOR TARGETING AND TREATING HOMOLOGOUS RECOMBINATION-DEFICIENT TUMORS | YALE UNIVERSITY (US) | 2017-12-07 | — | — | WO | disclosed |
| CN-103841848-B | Radioprotector and its method | 施特姆拉德有限公司 | 2017-12-05 | — | — | CN | disclosed |
| US-20170319698-A1 | GASTRORETENTIVE GEL FORMULATIONS | JAGOTEC AG (CH) | 2017-11-09 | — | — | US | disclosed |
| US-9770443-B2 | Aerosol pirfenidone and pyridone analog compounds and uses thereof | GENOA PHARMACEUTICALS, INC. (US) | 2017-09-26 | — | — | US | disclosed |
| EP-3212167-A1 | GASTRORETENTIVE GEL FORMULATIONS | Jagotec AG (CH) | 2017-09-06 | — | — | EP | disclosed |
| US-20170224706-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | GENOA PHARMACEUTICALS, INC. | 2017-08-10 | — | — | US | disclosed |
| US-9669137-B2 | Modified polylactide polymers | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2017-06-06 | — | — | US | disclosed |
| US-9669137-B2 | Modified polylactide polymers | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2017-06-06 | — | — | US | disclosed |
| WO-2017040864-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | First Wave Biopharma (US) | 2017-03-09 | — | — | WO | disclosed |
| US-20170056347-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FIRST WAVE BIO, INC. | 2017-03-02 | — | — | US | disclosed |
| EP-3128996-A1 | Novel 7-Dehydrocholesterol Derivatives and Methods Using Same | Women and Infants Hospital of Rhode Island Inc. (US) | 2017-02-15 | — | — | EP | disclosed |
| US-20170029459-A1 | Novel 7-Dehydrocholesterol Derivatives and Methods Using Same | WOMEN & INFANTS HOSPITAL OF RHODE ISLAND | 2017-02-02 | — | — | US | disclosed |
| EP-3091976-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | Genoa Pharmaceuticals Inc. (US) | 2016-11-16 | — | — | EP | disclosed |
| US-20160220785-A1 | DIAGNOSTIC CATHETERS, GUIDE CATHETERS, VISUALIZATION DEVICES AND CHORD MANIPULATION DEVICES, AND RELATED KITS AND METHODS | ANCORA HEART, INC. | 2016-08-04 | — | — | US | disclosed |
| EP-3035979-A1 | METHOD AND APPARATUS FOR MONITORING TOTAL DELIVERED DOSE OF CONTRAST MEDIA | Intersect Partners, LLC (US) | 2016-06-29 | — | — | EP | disclosed |
| CN-105658260-A | Method and apparatus for monitoring total delivered dose of contrast agent | 交叉合作公司 | 2016-06-08 | — | — | CN | disclosed |
| WO-2016066256-A1 | GASTRORETENTIVE GEL FORMULATIONS | JAGOTEC AG (CH) | 2016-05-06 | — | — | WO | disclosed |
| CN-105120908-A | Improved setting of hardenable bone substitute | BONE SUPPORT AB | 2015-12-02 | — | — | CN | disclosed |
| CN-103585577-B | A kind of preparation method for the treatment of the medicament of untoward reaction after radiography | DU ZHAOQIN (CN) | 2015-11-25 | — | — | CN | disclosed |
| US-9173646-B2 | Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods | GUIDED DELIVERY SYSTEMS INC. (US) | 2015-11-03 | — | — | US | disclosed |
| US-20150309021-A1 | Advanced Drug Development and Manufacturing | LOS ALAMOS NATIONAL SECURITY, LLC | 2015-10-29 | — | — | US | disclosed |
| WO-2015157262-A1 | Novel 7-Dehydrocholesterol Derivatives and Methods Using Same | WOMEN & INFANTS HOSPITAL OF RHODE ISLAND (US) | 2015-10-15 | — | — | WO | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| US-20150217028-A1 | MODIFIED PLA POLYMER AND METHOD OF MAKING AND USING | ABBOTT CARDIOVASCULAR SYSTEMS INC. | 2015-08-06 | — | — | US | disclosed |
| US-20150217028-A1 | MODIFIED PLA POLYMER AND METHOD OF MAKING AND USING | ABBOTT CARDIOVASCULAR SYSTEMS INC. | 2015-08-06 | — | — | US | disclosed |
| WO-2015106150-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | GENOA PHARMACEUTICALS INC. (US) | 2015-07-16 | — | — | WO | disclosed |
| US-20150196543-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | AVALYN PHARMA INC. | 2015-07-16 | — | — | US | disclosed |
| CN-103610935-B | Medicament for treating nausea and vomiting after radiography | CHEN MING | 2015-07-08 | — | — | CN | disclosed |
| EP-2877164-A2 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS | Genoa Pharmaceuticals, Inc. (US) | 2015-06-03 | — | — | EP | disclosed |
| US-20150057538-A1 | METHOD AND APPARATUS FOR MONITORING TOTAL DELIVERED DOSE OF CONTRAST MEDIA | INTERSECT PARTNERS LLC (US) | 2015-02-26 | — | — | US | disclosed |
| WO-2015027149-A1 | METHOD AND APPARATUS FOR MONITORING TOTAL DELIVERED DOSE OF CONTRAST MEDIA | INTERSECT PARTNERS, LLC (US) | 2015-02-26 | — | — | WO | disclosed |
| CN-104039343-A | He4 based therapy for malignant disease | WOMEN & INFANTS HOSPITAL OF RHODE ISLAND | 2014-09-10 | — | — | CN | disclosed |
| CN-103841848-A | Radiation protection device and methods thereof | STEMRAD LTD | 2014-06-04 | — | — | CN | disclosed |
| CN-103610935-A | Medicament for treating nausea and vomiting after radiography | CHEN MING | 2014-03-05 | — | — | CN | disclosed |
| CN-103585577-A | Preparation method of medicament for treatment of untoward effects after radiography | LI YINGCHUN | 2014-02-19 | — | — | CN | disclosed |
| WO-2014018668-A2 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | GENOA PHARMACEUTICALS, INC. (US) | 2014-01-30 | — | — | WO | disclosed |
| EP-2670242-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | Genoa Pharmaceuticals, Inc. (US) | 2013-12-11 | — | — | EP | disclosed |
| US-20130310424-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | AVALYN PHARMA INC. | 2013-11-21 | — | — | US | disclosed |
| US-20130225640-A1 | CYANOACRYLATE-BASED BIO-ADHESIVE COMPOSITION | INTUITIVE MEDI CORP INC. (KR) | 2013-08-29 | — | — | US | disclosed |
| US-20130225640-A1 | CYANOACRYLATE-BASED BIO-ADHESIVE COMPOSITION | INTUITIVE MEDI CORP INC. (KR) | 2013-08-29 | — | — | US | disclosed |
| US-20130225640-A1 | CYANOACRYLATE-BASED BIO-ADHESIVE COMPOSITION | INTUITIVE MEDI CORP INC. (KR) | 2013-08-29 | — | — | US | disclosed |
| US-20130225640-A1 | CYANOACRYLATE-BASED BIO-ADHESIVE COMPOSITION | INTUITIVE MEDI CORP INC. (KR) | 2013-08-29 | — | — | US | disclosed |
| US-8518373-B2 | Ionic and non-ionic radiographic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics | BRACCO IMAGING SPA (IT) | 2013-08-27 | — | — | US | disclosed |
| US-8501242-B2 | Methods and compositions for treating neoplasia | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) | 2013-08-06 | — | — | US | disclosed |
| US-8501242-B2 | Methods and compositions for treating neoplasia | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) | 2013-08-06 | — | — | US | disclosed |
| CN-103041364-A | Medicament for treating untoward effects after radiography | LI YINGCHUN | 2013-04-17 | — | — | CN | disclosed |
| US-20130023758-A1 | DIAGNOSTIC CATHETERS, GUIDE CATHETERS, VISUALIZATION DEVICES AND CHORD MANIPULATION DEVICES, AND RELATED KITS AND METHODS | Guided Delivery System Inc. (US) | 2013-01-24 | — | — | US | disclosed |
| EP-1189941-B1 | NEUROMEDIN B AND SOMATOSTATIN RECEPTOR AGONISTS | IPSEN PHARMA (FR) | 2013-01-09 | — | — | EP | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| WO-2012106382-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | GENOA PHARMACEUTICALS, INC. (US) | 2012-08-09 | — | — | WO | disclosed |
| US-20120192861-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | GENOA PHARMACEUTICALS, INC. (US) | 2012-08-02 | — | — | US | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| US-20120178984-A1 | BIO-ABSORBABLE BRACHYTHERAPY STRANDS | BIOCOMPATIBLES UK LIMITED (GB) | 2012-07-12 | — | — | US | disclosed |
| WO-2012060623-A3 | CYANOACRYLATE-BASED BIO-ADHESIVE COMPOSITION | (주)인튜이티브메디코프 (KR) | 2012-07-05 | — | — | WO | disclosed |
| US-8211404-B2 | Ionic and non-ionic radiograhic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics | BRACCO IMAGING S.P.A. (IT) | 2012-07-03 | — | — | US | disclosed |
| US-20120156212-A1 | METHODS AND COMPOSITIONS FOR TREATING NEOPLASIA | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION | 2012-06-21 | — | — | US | disclosed |
| WO-2012060623-A2 | CYANOACRYLATE-BASED BIO-ADHESIVE COMPOSITION | (주)인튜이티브메디코프 (KR) | 2012-05-10 | — | — | WO | disclosed |
| US-20120076734-A1 | RADIOPAQUE ANTIBIOTIC DENTAL PASTE AND USES THEREOF | OLSON JACOB (US) | 2012-03-29 | — | — | US | disclosed |
| WO-2012036798-A1 | DEVICES, METHODS AND KITS FOR HEART VALVE REPLACEMENT | GUIDED DELIVERY SYSTEMS INC. (US) | 2012-03-22 | — | — | WO | disclosed |
| EP-2389218-A1 | DIAGNOSTIC CATHETERS, GUIDE CATHETERS, VISUALIZATION DEVICES AND CHORD MANIPULATION DEVICES, AND RELATED KITS AND METHODS | Guided Delivery Systems, Inc. (US) | 2011-11-30 | — | — | EP | disclosed |
| US-20110254766-A1 | COMPUTER MOUSE CABLE REEL STOWAGE DEVICE | CHANG WEN-HAN | 2011-10-20 | — | — | US | disclosed |
| US-20110104052-A1 | METHODS OF SYNTHESIS AND USE OF CHEMOSPHERES | THE JOHNS HOPKINS UNIVERSITY (US) | 2011-05-05 | — | — | US | disclosed |
| CN-101945672-A | Biodegradable contrast agents | IOPHARMA TECHNOLOGIES AB | 2011-01-12 | — | — | CN | disclosed |
| WO-2010138955-A2 | METHODS AND COMPOSITIONS FOR TREATING NEOPLASIA | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2010-12-02 | — | — | WO | disclosed |
| CN-1929868-B | Lyposome-containing x ray-imaging agent and method for producing the same | KONICA MINOLTA MED & GRAPHIC | 2010-11-24 | — | — | CN | disclosed |
| EP-2240243-A1 | BIO-ABSORBABLE BRACHYTHERAPY STRANDS | Biocompatibles UK Limited (GB) | 2010-10-20 | — | — | EP | disclosed |
| EP-2229147-A2 | METHODS OF SYNTHESIS AND USE OF CHEMOSPHERES | The Johns Hopkins University (US) | 2010-09-22 | — | — | EP | disclosed |
| US-20100198056-A1 | Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods | GUIDED DELIVERY SYSTEMS INC. | 2010-08-05 | — | — | US | disclosed |
| US-20100198208-A1 | DIAGNOSTIC CATHETERS, GUIDE CATHETERS, VISUALIZATION DEVICES AND CHORD MANIPULATION DEVICES, AND RELATED KITS AND METHODS | GUIDED DELIVERY SYSTEMS INC. | 2010-08-05 | — | — | US | disclosed |
| WO-2010085457-A1 | DIAGNOSTIC CATHETERS, GUIDE CATHETERS, VISUALIZATION DEVICES AND CHORD MANIPULATION DEVICES, AND RELATED KITS AND METHODS | GUIDED DELIVERY SYSTEMS INC. (US) | 2010-07-29 | — | — | WO | disclosed |
| US-20100185172-A1 | DIAGNOSTIC CATHETERS, GUIDE CATHETERS, VISUALIZATION DEVICES AND CHORD MANIPULATION DEVICES, AND RELATED KITS AND METHODS | GUIDED DELIVERY SYSTEMS INC. | 2010-07-22 | — | — | US | disclosed |
| US-20100135913-A1 | Ionic and Non-Ionic Radiographic Contrast Agents for Use in Combined X-ray and Nuclear Magnetic Resonance Diagnostics | BRACCO IMAGING S.P.A. (IT) | 2010-06-03 | — | — | US | disclosed |
| US-7588751-B2 | Liposome-containing radiographic contrast medium and preparation method thereof | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-09-15 | — | — | US | disclosed |
| US-20090216063-A1 | BIO-ABSORBABLE BRACHYTHERAPY STRANDS | BIOCOMPATIBLES UK LIMITED (GB) | 2009-08-27 | — | — | US | disclosed |
| WO-2009097408-A1 | BIO-ABSORBABLE BRACHYTHERAPY STRANDS | BIOCOMPATIBLES UK LIMITED (GB) | 2009-08-06 | — | — | WO | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| US-20090192592-A1 | POROUS IMPLANT STRUCTURE | CINVENTION AG (DE) | 2009-07-30 | — | — | US | disclosed |
| WO-2009073193-A2 | METHODS OF SYNTHESIS AND USE OF CHEMOSPHERES | THE JOHNS HOPKINS UNIVERSITY (US) | 2009-06-11 | — | — | WO | disclosed |
| EP-1299718-A4 | RADIO-OPAQUE POLYMERIC COMPOSITIONS | HYDROMER INC (US) | 2009-04-29 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080249638-A1 | BIODEGRADABLE THERAPEUTIC IMPLANT FOR BONE OR CARTILAGE REPAIR | CINVENTION AG (DE) | 2008-10-09 | — | — | US | disclosed |
| US-20080249637-A1 | PARTIALLY BIODEGRADABLE THERAPEUTIC IMPLANT FOR BONE AND CARTILAGE REPAIR | CINVENTION AG (DE) | 2008-10-09 | — | — | US | disclosed |
| US-20080248086-A1 | CURABLE THERAPEUTIC IMPLANT COMPOSITION | CINVENTION AG (DE) | 2008-10-09 | — | — | US | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |
| US-20080213611-A1 | POROUS, NON-DEGRADABLE IMPLANT MADE BY POWDER MOLDING | CINVENTION AG (DE) | 2008-09-04 | — | — | US | disclosed |
| US-20080200976-A1 | CARBON STENTS | CINVENTION AG (DE) | 2008-08-21 | — | — | US | disclosed |
| US-20080200586-A1 | Dental/Surgical Sealants Including Shapeable Particles | DRFP HOLDINGS LIMITED (GB) | 2008-08-21 | — | — | US | disclosed |
| US-20080195198-A1 | DEGRADABLE POROUS IMPLANT STRUCTURE | CINVENTION AG (DE) | 2008-08-14 | — | — | US | disclosed |
| US-20080195189-A1 | DEGRADABLE RESERVOIR IMPLANTS | CINVENTION AG (DE) | 2008-08-14 | — | — | US | disclosed |
| US-20080195170-A1 | MEDICAL DEVICE WITH EXTENDED OR MULTIPLE RESERVOIRS | CINVENTION AG (DE) | 2008-08-14 | — | — | US | disclosed |
| US-20080195196-A1 | RESERVOIR IMPLANTS AND STENTS | CINVENTION AG (DE) | 2008-08-14 | — | — | US | disclosed |
| US-20080175885-A1 | POROUS, DEGRADABLE IMPLANT MADE BY POWDER MOLDING | CINVENTION AG (DE) | 2008-07-24 | — | — | US | disclosed |
| US-20080177378-A1 | PARTIALLY BIOABSORBABLE IMPLANT | CIVENTION AG (DE) | 2008-07-24 | — | — | US | disclosed |
| US-20080132453-A1 | Neuromedin B and somatostatin receptor agonists | IPSEN PHARMA S.A.S. (FR) | 2008-06-05 | — | — | US | disclosed |
| CN-1988919-A | Liposome-containing radiographic contrast medium and preparation method thereof | KONICA MINOLTA MED & GRAPHIC (JP) | 2007-06-27 | — | — | CN | disclosed |
| EP-1772156-A1 | LIPOSOME-CONTAINING X-RAY RADIOPAQUE DYE AND PROCESS FOR PRODUCING THE SAME | Konica Minolta Medical & Graphic, Inc. (JP) | 2007-04-11 | — | — | EP | disclosed |
| EP-1768715-A1 | DENTAL/SURGICAL SEALANTS INCLUDING SHAPEABLE PARTICLES | DRFP Holdings Limited (GB) | 2007-04-04 | — | — | EP | disclosed |
| US-7196023-B2 | Chemically resistant radiation attenuation barrier | KAPPLER, INC. (US) | 2007-03-27 | — | — | US | disclosed |
| CN-1929868-A | Lyposome-containing x ray-imaging agent and method for producing the same | KONICA MINOLTA MED & GRAPHIC (JP) | 2007-03-14 | — | — | CN | disclosed |
| EP-1411992-B1 | IONIC AND NON-IONIC RADIOGRAPHIC CONTRAST AGENTS FOR USE IN COMBINED X-RAY AND NUCLEAR MAGNETIC RESONANCE DIAGNOSTICS | BRACCO IMAGING SPA (IT) | 2006-12-13 | — | — | EP | disclosed |
| US-7109377-B2 | Synthesis of combinatorial libraries of compounds reminiscent of natural products | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2006-09-19 | — | — | US | disclosed |
| US-20060177379-A1 | Composition comprising an agent providing a signal, an implant material and a drug | CINVENTION AG (DE) | 2006-08-10 | — | — | US | disclosed |
| EP-1679084-A1 | X-RAY CONTRAST MEDIUM CONTAINING LIPOSOME AND METHOD FOR PREPARATION THEREOF | Konica Minolta Medical & Graphic Inc. (JP) | 2006-07-12 | — | — | EP | disclosed |
| US-20060025378-A1 | Dose dependent elimination of HA and cell receptor stimulation | PILARSKI LINDA M | 2006-02-02 | — | — | US | disclosed |
| US-20060018828-A1 | Liposome-containing radiographic contrast medium and preparation method thereof | KONICA MINOLTA MEDICAL & GRAPHIC, INC. | 2006-01-26 | — | — | US | disclosed |
| WO-2006008499-A1 | DENTAL/SURGICAL SEALANTS INCLUDING SHAPEABLE PARTICLES | DRFP HOLDINGS LIMITED (GB) | 2006-01-26 | — | — | WO | disclosed |
| CN-1689120-A | Multiple hazard prevention article and method of making same | MERIDIAN RES & DEV (US) | 2005-10-26 | — | — | CN | disclosed |
| US-20050191918-A1 | Chemically resistant radiation attenuation barrier | KAPPLER, INC. | 2005-09-01 | — | — | US | disclosed |
| EP-1423107-A4 | FATTY ALCOHOL DRUG CONJUGATES | LUITPOLD PHARM INC (US) | 2005-08-17 | — | — | EP | disclosed |
| US-6903074-B1 | Neuromedin b and somatostatin receptor agonists | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. (FR) | 2005-06-07 | — | — | US | disclosed |
| US-20050113675-A1 | Ionic and non-ionic radiograhic contrast agents for use in combined x-ray and nuclear magnetic resonance diagnostics | BRACCO IMAGING S.P.A. (IT) | 2005-05-26 | — | — | US | disclosed |
| EP-1427407-A4 | FATTY AMINE DRUG CONJUGATES | LUITPOLD PHARM INC (US) | 2005-05-11 | — | — | EP | disclosed |
| US-20050084453-A1 | Liposome-containing radiographic contrast medium and preparation method thereof | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2005-04-21 | — | — | US | disclosed |
| EP-1427407-A2 | FATTY AMINE DRUG CONJUGATES | Protarga Inc. (US) | 2004-06-16 | — | — | EP | disclosed |
| EP-1423107-A2 | FATTY ALCOHOL DRUG CONJUGATES | Protarga, Inc. (US) | 2004-06-02 | — | — | EP | disclosed |
| US-20040082079-A1 | Low affinity screening method | GRAFFINITY PHARMACEUTICALS AG. (DE) | 2004-04-29 | — | — | US | disclosed |
| EP-1411992-A1 | IONIC AND NON-IONIC RADIOGRAPHIC CONTRAST AGENTS FOR USE IN COMBINED X-RAY AND NUCLEAR MAGNETIC RESONANCE DIAGNOSTICS | Bracco Imaging S.p.A. (IT) | 2004-04-28 | — | — | EP | disclosed |
| EP-1360489-A1 | LOW AFFINITY SCREENING METHOD | Graffinity Pharmaceuticals Aktiengesellschaft (DE) | 2003-11-12 | — | — | EP | disclosed |
| US-6599448-B1 | Polymer or monomer has a nonleachable radio-opaque moiety; coating for medical equipment; with an antithrombotic agent | HYDROMER, INC. | 2003-07-29 | — | — | US | disclosed |
| US-6575888-B2 | Bioabsorbable brachytherapy device | BIOSURFACE ENGINEERING TECHNOLOGIES, INC. | 2003-06-10 | — | — | US | disclosed |
| US-6558665-B1 | Encapsulating particles with coatings that conform to size and shape of the particles | ARCH DEVELOPMENT CORPORATION | 2003-05-06 | — | — | US | disclosed |
| US-20030082830-A1 | Synthesis of combinatorial libraries of compounds reminiscent of natural products | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-05-01 | — | — | US | disclosed |
| EP-1299718-A1 | RADIO-OPAQUE POLYMERIC COMPOSITIONS | Hydromer, Inc. (US) | 2003-04-09 | — | — | EP | disclosed |
| WO-2003013616-A1 | IONIC AND NON-IONIC RADIOGRAPHIC CONTRAST AGENTS FOR USE IN COMBINED X-RAY AND NUCLEAR MAGNETIC RESONANCE DIAGNOSTICS | BRACCO IMAGING S.P.A. (IT) | 2003-02-20 | — | — | WO | disclosed |
| US-6465174-B1 | EXPOSURE OF LIGHT SENSITIVE FLUID CONTAINING METHYLENE BLUE, N,N,N*,N*-TETRAMETHYLETHYLENEDIAMINE, AND ACRYLAMIDE TO LIGHT PATTERN CAUSING COALESCENCE AND ADHESION | UNIVERSITY OF CHICAGO | 2002-10-15 | — | — | US | disclosed |
| WO-2002076402-A2 | FATTY AMINE DRUG CONJUGATES | PROTARGA, INC. (US) | 2002-10-03 | — | — | WO | disclosed |
| WO-2002076404-A2 | FATTY ALCOHOL DRUG CONJUGATES | PROTARGA, INC. (US) | 2002-10-03 | — | — | WO | disclosed |
| US-6448443-B1 | GENERATED FROM DIVERSIFIABLE SCAFFOLDS SYNTHESIZED FROM THE PYRIDINE-BASED TEMPLATE ISONICOTINAMIDE; ALSO PROVIDES A NOVEL ORTHO-NITROBENZYL PHOTOLINKER; SYNTHESIZED FROM A SHIKIMIC ACID BASED EPOXYOL TEMPLATE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2002-09-10 | — | — | US | disclosed |
| WO-2002063299-A1 | LOW AFFINITY SCREENING METHOD | GRAFFINITY PHARMACEUTICALS AG (DE) | 2002-08-15 | — | — | WO | disclosed |
| EP-1189941-A1 | NEUROMEDIN B AND SOMATOSTATIN RECEPTOR AGONISTS | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S. (FR) | 2002-03-27 | — | — | EP | disclosed |
| US-20010044567-A1 | Bioabsorbable brachytherapy device | FERRING B.V. (NL) | 2001-11-22 | — | — | US | disclosed |
| WO-2001085214-A1 | RADIO-OPAQUE POLYMERIC COMPOSITIONS | HYDROMER, INC. (US) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001054764-A2 | BIOABSORBABLE BRACHYTHERAPY DEVICE | BIOSURFACE ENGINEERING TECHNOLOGIES, INC (US) | 2001-08-02 | — | — | WO | disclosed |
| WO-2000075186-A1 | NEUROMEDIN B AND SOMATOSTATIN RECEPTOR AGONISTS | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES SAS (FR) | 2000-12-14 | — | — | WO | disclosed |
| WO-2000006525-A9 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | HARVARD COLLEGE (US) | 2000-04-20 | — | — | WO | disclosed |
| WO-2000006525-A2 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-02-10 | — | — | WO | disclosed |
| EP-0314764-B2 | INJECTABLE OPACIFYING LIPOSOME COMPOSITION | DIBRA SPA (IT) | 2000-02-02 | — | — | EP | disclosed |
| EP-0774970-A4 | METHOD OF USING HYALURONIC ACID FOR THE DETECTION, LOCATION AND DIAGNOSIS OF TUMORS | COWARD RODERICK T (CA) | 2000-02-02 | — | — | EP | disclosed |
| EP-0694809-B1 | A novel class of grain growth modifiers for the preparation of high chloride (111) tabular grain emulsions (II) | EASTMAN KODAK CO (US) | 1999-10-06 | — | — | EP | disclosed |
| EP-0335545-B2 | Pharmaceutical formulations for parenteral use | UNIV FLORIDA (US) | 1998-09-23 | — | — | EP | disclosed |
| EP-0619716-B1 | CONTRAST MEDIA | NYCOMED IMAGING AS (NO) | 1998-08-05 | — | — | EP | disclosed |
| US-5772982-A | Method of using hyaluronic acid for the detection, location and diagnosis of tumors | COWARD RODERICK T (CA) | 1998-06-30 | — | — | US | disclosed |
| US-5733525-A | Method of EII using a water insoluble particulate agent | NYCOMED IMAGING AS (NO) | 1998-03-31 | — | — | US | disclosed |
| US-5651955-A | Method of electrical impedance imaging using ionic metal chelates | NYCOMED IMAGING AS (NO) | 1997-07-29 | — | — | US | disclosed |
| US-5639444-A | Method of electrical impedance imaging using a triiodophenyl compound or gas encapsulated microbubbles | NYCOMED IMAGING AS (NO) | 1997-06-17 | — | — | US | disclosed |
| EP-0774970-A1 | METHOD OF USING HYALURONIC ACID FOR THE DETECTION, LOCATION AND DIAGNOSIS OF TUMORS | Coward, Roderick T. (CA) | 1997-05-28 | — | — | EP | disclosed |
| US-5626832-A | IODINATED CONTRAST AGENT | BRACCO S.P.A. (IT) | 1997-05-06 | — | — | US | disclosed |
| EP-0746339-A1 | X-RAY CONTRAST COMPOSITIONS CONTAINING CELLULOSE DERIVATIVES | NYCOMED IMAGING AS (NO) | 1996-12-11 | — | — | EP | disclosed |
| US-5525327-A | Polymeric x-ray contrast compositions containing iodinated polymeric beads and microcrystaline cellulose | STERLING WINTHROP INC. (US) | 1996-06-11 | — | — | US | disclosed |
| US-5525727-A | ANALGESIC OR NARCOTIC ANTAGONIST | UNIVERSITY OF FLORIDA (US) | 1996-06-11 | — | — | US | disclosed |
| WO-1996004922-A1 | METHOD OF USING HYALURONIC ACID FOR THE DETECTION, LOCATION AND DIAGNOSIS OF TUMORS | DAVIS, JOANNE, T. (US) | 1996-02-22 | — | — | WO | disclosed |
| EP-0695195-A1 | POLYMERIC X-RAY CONTRAST COMPOSITIONS CONTAINING IODINATED POLYMERIC BEADS | NYCOMED IMAGING AS (NO) | 1996-02-07 | — | — | EP | disclosed |
| EP-0514523-B1 | METHOD FOR MAKING LIPOSOMES OF ENHANCED ENTRAPPING CAPACITY TOWARD FOREIGN SUBSTANCES TO BE ENCAPSULATED | BRACCO INT BV (NL) | 1995-12-20 | — | — | EP | disclosed |
| WO-1995022995-A1 | X-RAY CONTRAST COMPOSITIONS CONTAINING CELLULOSE DERIVATIVES | NYCOMED IMAGING A/S (NO) | 1995-08-31 | — | — | WO | disclosed |
| US-5445810-A | Containing iodinated organic compounds | BRACCO INTERNATIONAL B.V. (NL) | 1995-08-29 | — | — | US | disclosed |
| EP-0110955-B1 | BRAIN-SPECIFIC DRUG DELIVERY | UNIV FLORIDA (US) | 1995-08-23 | — | — | EP | disclosed |
| US-5393530-A | Contacting comminuted mixture of lipids with aqueous liquid carrier phase, forming suspension of liposome vesicles, introducing substance to be encapsulated, incubating to load by transmembrane permeation | BRACCO INTERNATIONAL B.V. (NL) | 1995-02-28 | — | — | US | disclosed |
| US-5389623-A | Redox carriers for brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1995-02-14 | — | — | US | disclosed |
| WO-1994025075-A1 | POLYMERIC X-RAY CONTRAST COMPOSITIONS CONTAINING IODINATED POLYMERIC BEADS | STERLING WINTHROP INC. (US) | 1994-11-10 | — | — | WO | disclosed |
| US-5346690-A | Composition of a superparamagnetic or ferromagnetic particle and an X-ray contrast agent for MRI | NYCOMED IMAGING AS (NO) | 1994-09-13 | — | — | US | disclosed |
| US-5342605-A | For x-ray examination of intestinal tract; forming thin film on mucosal lining; barrier | STERLING WINTHROP INC. (US) | 1994-08-30 | — | — | US | disclosed |
| US-5312615-A | Encapsulation, extrusion and filtration of liposomes | BRACCO - INDUSTRIA CHIMICA S.P.A. (IT) | 1994-05-17 | — | — | US | disclosed |
| EP-0414288-B1 | Contrast media | NYCOMED IMAGING AS (NO) | 1994-03-23 | — | — | EP | disclosed |
| EP-0414287-B1 | Particulate contrast media | NYCOMED IMAGING AS (NO) | 1994-01-19 | — | — | EP | disclosed |
| US-5242683-A | Gastrointestinal tract, side effect reduction | NYCOMED IMAGING AS (NO) | 1993-09-07 | — | — | US | disclosed |
| US-5187158-A | Sustained delivery of viricides | UNIVERSITY OF FLORIDA (US) | 1993-02-16 | — | — | US | disclosed |
| EP-0514523-A1 | METHOD FOR MAKING LIPOSOMES OF ENHANCED ENTRAPPING CAPACITY TOWARD FOREIGN SUBSTANCES TO BE ENCAPSULATED. | SINT SA (CH) | 1992-11-25 | — | — | EP | disclosed |
| EP-0314764-B1 | INJECTABLE OPACIFYING LIPOSOME COMPOSITION | DIBRA S.p.A. (IT) | 1992-09-09 | — | — | EP | disclosed |
| WO-1992010166-A1 | METHOD FOR MAKING LIPOSOMES OF ENHANCED ENTRAPPING CAPACITY TOWARD FOREIGN SUBSTANCES TO BE ENCAPSULATED | SINTETICA S.A. (CH) | 1992-06-25 | — | — | WO | disclosed |
| EP-0483278-A1 | PARTICULATE CONTRAST MEDIA | NYCOMED AS (NO) | 1992-05-06 | — | — | EP | disclosed |
| US-5087618-A | Antiviral, anticancer, antitumor agents | UNIVERSITY OF FLORIDA (US) | 1992-02-11 | — | — | US | disclosed |
| US-5024998-A | Administering in aqueous solution with cyclodextrin derivative | UNIVERSITY OF FLORIDA (US) | 1991-06-18 | — | — | US | disclosed |
| US-5017566-A | Redox systems for brain-targeted drug delivery | UNIVERSITY OF FLORIDA (US) | 1991-05-21 | — | — | US | disclosed |
| US-5008257-A | Penicillin or cephalosporin antibiotics | UNIVERSITY OF FLORIDA (US) | 1991-04-16 | — | — | US | disclosed |
| US-5002935-A | Inclusion Complexing Hydroxypropylcyclodextrin with a Dihydropyridine-substituted Drug | UNIVERSITY OF FLORIDA (US) | 1991-03-26 | — | — | US | disclosed |
| EP-0414287-A1 | Particulate contrast media | NYCOMED IMAGING AS (NO) | 1991-02-27 | — | — | EP | disclosed |
| EP-0414288-A1 | Contrast media | NYCOMED IMAGING AS (NO) | 1991-02-27 | — | — | EP | disclosed |
| WO-1991001147-A1 | PARTICULATE CONTRAST MEDIA | NYCOMED AS (NO) | 1991-02-07 | — | — | WO | disclosed |
| US-4983586-A | Decreasing precipitation at injection site or in lungs or other organs by combining with hydroxypropyl-beta-cyclodextrin | UNIVERSITY OF FLORIDA (US) | 1991-01-08 | — | — | US | disclosed |
| EP-0386960-A2 | Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings | AMERICAN CYANAMID COMPANY (US) | 1990-09-12 | — | — | EP | disclosed |
| US-4900837-A | Brain-specific drug delivery of steroid sex hormones cleaved from pyridinium carboxylates and dihydro-pyridine carboxylate precursors | UNIVERSITY OF FLORIDA (US) | 1990-02-13 | — | — | US | disclosed |
| US-4880921-A | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1989-11-14 | — | — | US | disclosed |
| EP-0335545-A2 | Pharmaceutical formulations for parenteral use | UNIVERSITY OF FLORIDA (US) | 1989-10-04 | — | — | EP | disclosed |
| EP-0327766-A2 | Redox systems for brain-targeted drug delivery | UNIVERSITY OF FLORIDA (US) | 1989-08-16 | — | — | EP | disclosed |
| US-4830858-A | Spray-drying method for preparing liposomes and products produced thereby | E. R. SQUIBB & SONS, INC. (US) | 1989-05-16 | — | — | US | disclosed |
| EP-0314764-A1 | INJECTABLE OPACIFYING LIPOSOME COMPOSITION. | BRACCO IND CHIMICA SPA (IT) | 1989-05-10 | — | — | EP | disclosed |
| US-4829070-A | PRODRUG FOR SUSTAINED RELEASE OF DOPAMINE | UNIVERSITY OF FLORIDA (US) | 1989-05-09 | — | — | US | disclosed |
| US-4824850-A | DIHYDROPYRIDINE-PYRIDINIUM SALT REDOX CARRIER | UNIVERSITY OF FLORIDA (US) | 1989-04-25 | — | — | US | disclosed |
| WO-1988009165-A1 | INJECTABLE OPACIFYING LIPOSOME COMPOSITION | BRACCO INDUSTRIA CHIMICA S.P.A. (IT) | 1988-12-01 | — | — | WO | disclosed |
| EP-0119020-B1 | METHOD OF PREPARING LIPOSOMES AND PRODUCTS PRODUCED THEREBY | E.R. Squibb & Sons, Inc. (US) | 1988-06-01 | — | — | EP | disclosed |
| US-4744989-A | THIN FILMS OF LIPOSOMES ON CARRIERS | E. R. SQUIBB & SONS, INC. (US) | 1988-05-17 | — | — | US | disclosed |
| EP-0224283-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1987-06-03 | — | — | EP | disclosed |
| EP-0222425-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1987-05-20 | — | — | EP | disclosed |
| EP-0218300-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1987-04-15 | — | — | EP | disclosed |
| US-4540564-A | DIHYDROPYRIDINE AND/OR PYRIDINIUM SALT REDOX CARRIER | UNIVERSITY OF FLORIDA (US) | 1985-09-10 | — | — | US | disclosed |
| EP-0070198-B1 | RADIATION-SENSITIVE COMPOSITION AND PATTERN-FORMATION METHOD USING THE SAME | Hitachi, Ltd. (JP) | 1985-06-19 | — | — | EP | disclosed |
| US-4479932-A | DIHYDROPYRIDINE PYRIDINIUM SALT REDOX CARRIER | UNIVERSITY OF FLORIDA (US) | 1984-10-30 | — | — | US | disclosed |
| EP-0119020-A2 | Method of preparing liposomes and products produced thereby | E.R. Squibb & Sons, Inc. (US) | 1984-09-19 | — | — | EP | disclosed |
| US-4465768-A | Pattern-formation method with iodine containing azide and oxygen plasma etching of substrate | HITACHI, LTD. (JP) | 1984-08-14 | — | — | US | disclosed |
| EP-0110955-A1 | BRAIN-SPECIFIC DRUG DELIVERY. | UNIV FLORIDA (US) | 1984-06-20 | — | — | EP | disclosed |
| WO-1983003968-A1 | BRAIN-SPECIFIC DRUG DELIVERY | UNIVERSITY OF FLORIDA (US) | 1983-11-24 | — | — | WO | disclosed |
| US-4406878-A | Iodinated contrast agent for radiography | EASTMAN KODAK COMPANY (US) | 1983-09-27 | — | — | US | disclosed |
| EP-0070198-A1 | Radiation-sensitive composition and pattern-formation method using the same | Hitachi, Ltd. (JP) | 1983-01-19 | — | — | EP | disclosed |
| US-4192859-A | MEDICAL DIAGNOSIS USING X-RAYS | E. R. SQUIBB & SONS, INC. (US) | 1980-03-11 | — | — | US | disclosed |
| US-4175544-A | X-RAYS OF BODY FOR MEDICAL DIAGNOSIS | Lafayette Pharmacal Inc. (US) | 1979-11-27 | — | — | US | disclosed |
| US-4153693-A | 1,4-Dihydro-4-oxo-pyridylacetamido cephalosporins and their utilization as medicinal agents for combating bacterial infections | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1979-05-08 | — | — | US | disclosed |
| US-4119775-A | ANTIBACTERIAL | RICHARDSON-MERRELL INC. (US) | 1978-10-10 | — | — | US | disclosed |
| US-3989687-A | ANTIBACTERIAL | RICHARDSON-MERRELL INC. (US) | 1976-11-02 | — | — | US | disclosed |
| US-3978072-A | ANTIINFLAMMATORY | ABIC LTD. (IL) | 1976-08-31 | — | — | US | disclosed |
| US-3978072-A | ANTIINFLAMMATORY | ABIC LTD. (IL) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210401784-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSE | FH, CS, ECHS1 | AKR1B1 2061/4885ALDH1A1 2230/4885KDM4E 2466/4885 |
| US-10105356-B2 | Aerosol pirfenidone and pyridone analog compounds and uses thereof | PLPBP, PIR, PDXK | AKR1B1 275/4885ALDH1A1 167/4885KDM4E 2879/4885 |
| US-20180273580-A1 | NOVEL 7-DEHYDROCHOLESTEROL DERIVATIVES AND METHODS USING SAME | DHCR7, CYP46A1, CYP27A1 | AKR1B1 169/4885ALDH1A1 731/4885KDM4E 694/4885 |
| US-20060018828-A1 | Liposome-containing radiographic contrast medium and preparation method thereof | SGMS1, SGMS2, PHOSPHO1 | AKR1B1 3077/4885ALDH1A1 4549/4885KDM4E 3144/4885 |
| US-20230295146-A1 | INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES 1 AND 4 | IRAK4, IRAK1, IRAK2 | AKR1B1 2308/4885ALDH1A1 2139/4885KDM4E 896/4885 |
| US-20230149375-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | PLPBP, PIR, PDXK | AKR1B1 275/4885ALDH1A1 167/4885KDM4E 2879/4885 |
| US-20200147012-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FH, CS, ECHS1 | AKR1B1 2158/4885ALDH1A1 2174/4885KDM4E 2452/4885 |
| US-20200197339-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FH, CS, ECHS1 | AKR1B1 2125/4885ALDH1A1 2168/4885KDM4E 2421/4885 |
| US-20240074995-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FH, CS, ECHS1 | AKR1B1 2158/4885ALDH1A1 2174/4885KDM4E 2452/4885 |
| US-20200268694-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FH, CS, ECHS1 | AKR1B1 2125/4885ALDH1A1 2168/4885KDM4E 2421/4885 |
| US-10610536-B2 | Aerosol pirfenidone and pyridone analog compounds and uses thereof | PLPBP, PIR, PDXK | AKR1B1 275/4885ALDH1A1 167/4885KDM4E 2879/4885 |
| US-20150217028-A1 | MODIFIED PLA POLYMER AND METHOD OF MAKING AND USING | PLAA, PARG, PHYKPL | AKR1B1 3439/4885ALDH1A1 2633/4885KDM4E 2017/4885 |
| US-11224592-B2 | Aerosol pirfenidone and pyridone analog compounds and uses thereof | PLPBP, PIR, PDXK | AKR1B1 275/4885ALDH1A1 167/4885KDM4E 2879/4885 |
| US-20210114973-A1 | PHARMACEUTICAL FORMULATIONS | NCSTN, CACNA1B, CACNA1A | AKR1B1 4684/4885ALDH1A1 3307/4885KDM4E 1788/4885 |
| US-10744103-B2 | Methods and compositions for treating conditions associated with an abnormal inflammatory responses | FH, CS, ECHS1 | AKR1B1 2158/4885ALDH1A1 2174/4885KDM4E 2452/4885 |
| US-20190298670-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FH, CS, ECHS1 | AKR1B1 2125/4885ALDH1A1 2168/4885KDM4E 2421/4885 |
| US-20170029459-A1 | Novel 7-Dehydrocholesterol Derivatives and Methods Using Same | DHCR7, CYP46A1, CYP27A1 | AKR1B1 169/4885ALDH1A1 731/4885KDM4E 694/4885 |
| US-10849867-B2 | Methods and compositions for treating conditions associated with an abnormal inflammatory response | FH, CS, ECHS1 | AKR1B1 2061/4885ALDH1A1 2230/4885KDM4E 2466/4885 |
| US-20210069165-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | PLPBP, PIR, PDXK | AKR1B1 275/4885ALDH1A1 167/4885KDM4E 2879/4885 |
| US-20230190684-A1 | METHODS OF TREATING COVID-19 WITH A NICLOSAMIDE COMPOUND | ACE2, ACE, MME | AKR1B1 4275/4885ALDH1A1 3497/4885KDM4E 3245/4885 |
| US-20200197340-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FH, CS, ECHS1 | AKR1B1 2158/4885ALDH1A1 2174/4885KDM4E 2452/4885 |
| US-20130225640-A1 | CYANOACRYLATE-BASED BIO-ADHESIVE COMPOSITION | ICAM1, DSC1, PLOD1 | AKR1B1 192/4885ALDH1A1 94/4885KDM4E 1926/4885 |
| US-20150196543-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | PLPBP, PIR, PDXK | AKR1B1 275/4885ALDH1A1 167/4885KDM4E 2879/4885 |
| US-10799468-B2 | Methods and compositions for treating conditions associated with an abnormal inflammatory responses | FH, CS, ECHS1 | AKR1B1 2125/4885ALDH1A1 2168/4885KDM4E 2421/4885 |
| US-20240261447-A1 | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO THE HEPATOPANCREATIC ANATOMICAL REGION | PNLIP, PYGL, RXFP1 | AKR1B1 487/4885ALDH1A1 2315/4885KDM4E 3928/4885 |
| US-20220218683-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | PLPBP, PIR, PDXK | AKR1B1 275/4885ALDH1A1 167/4885KDM4E 2879/4885 |
| US-20200405704-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | PLPBP, PIR, PDXK | AKR1B1 275/4885ALDH1A1 167/4885KDM4E 2879/4885 |
| US-10292951-B2 | Methods and compositions for treating conditions associated with an abnormal inflammatory responses | FH, CS, ECHS1 | AKR1B1 2125/4885ALDH1A1 2168/4885KDM4E 2421/4885 |
| US-20220079897-A1 | METHODS OF TREATMENT | ACE2, ACE, SI | AKR1B1 4396/4885ALDH1A1 3977/4885KDM4E 3249/4885 |
| US-11744812-B2 | Methods of treatment | ACE2, ACE, SI | AKR1B1 4396/4885ALDH1A1 3977/4885KDM4E 3249/4885 |
| US-10912746-B2 | Methods and compositions for treating conditions associated with an abnormal inflammatory response | FH, CS, ECHS1 | AKR1B1 2109/4885ALDH1A1 2238/4885KDM4E 2512/4885 |
| US-20200306264-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUND AND USES THEREOF | PLPBP, PIR, PDXK | AKR1B1 287/4885ALDH1A1 181/4885KDM4E 2831/4885 |
| US-20240299299-A1 | COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES | IL2, CD47, IFNG | AKR1B1 287/4885ALDH1A1 2368/4885KDM4E 1988/4885 |
| US-20230201143-A1 | METHODS OF TREATMENT | ACE2, ACE, SI | AKR1B1 4241/4885ALDH1A1 3889/4885KDM4E 3157/4885 |
| US-20230159586-A1 | INHIBITORS OF HUMAN EPIDIDYMUS PROTEIN 4 | MAN2B2, NASP, BRDT | AKR1B1 2193/4885ALDH1A1 1909/4885KDM4E 2574/4885 |
| US-10028966-B2 | Aerosol pirfenidone and pyridone analog compounds and uses thereof | PLPBP, PIR, PDXK | AKR1B1 275/4885ALDH1A1 167/4885KDM4E 2879/4885 |
| US-11564896-B2 | Methods of treatment | ACE2, ACE, SI | AKR1B1 4241/4885ALDH1A1 3889/4885KDM4E 3157/4885 |
| US-20250114376-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | PLPBP, PIR, PDXK | AKR1B1 275/4885ALDH1A1 167/4885KDM4E 2879/4885 |
| US-20220105057-A1 | METHODS OF TREATMENT | ACE2, ACE, SI | AKR1B1 4241/4885ALDH1A1 3889/4885KDM4E 3157/4885 |
| US-20200291060-A1 | NOVEL 7-DEHYDROCHOLESTEROL DERIVATIVES AND METHODS USING SAME | DHCR7, CYP46A1, CYP27A1 | AKR1B1 169/4885ALDH1A1 731/4885KDM4E 694/4885 |
| US-11559520-B2 | Aerosol pirfenidone and pyridone analog compounds and uses thereof | PLPBP, PIR, PDXK | AKR1B1 275/4885ALDH1A1 167/4885KDM4E 2879/4885 |
| US-20050084453-A1 | Liposome-containing radiographic contrast medium and preparation method thereof | LIPA, SGMS1, CHMP4B | AKR1B1 4750/4885ALDH1A1 4826/4885KDM4E 3421/4885 |
| US-20170056347-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FH, CS, ECHS1 | AKR1B1 2125/4885ALDH1A1 2168/4885KDM4E 2421/4885 |
| US-10683324-B2 | 7-dehydrocholesterol derivatives and methods using same | DHCR7, CYP46A1, CYP27A1 | AKR1B1 206/4885ALDH1A1 671/4885KDM4E 692/4885 |
| US-11034719-B2 | 7-dehydrocholesterol derivatives and methods using same | DHCR7, CYP46A1, CYP27A1 | AKR1B1 206/4885ALDH1A1 671/4885KDM4E 692/4885 |
| US-20250367178-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | PLPBP, PIR, PDXK | AKR1B1 275/4885ALDH1A1 167/4885KDM4E 2879/4885 |
| US-20120192861-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | PLPBP, PIR, PDXK | AKR1B1 275/4885ALDH1A1 167/4885KDM4E 2879/4885 |
| US-20230102999-A1 | DEUTERATED NICLOSAMIDE | FH, IDH2, ECHS1 | AKR1B1 3415/4885ALDH1A1 2305/4885KDM4E 2021/4885 |
| US-20190054076-A1 | AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF | PLPBP, PIR, PDXK | AKR1B1 275/4885ALDH1A1 167/4885KDM4E 2879/4885 |
| US-20080132453-A1 | Neuromedin B and somatostatin receptor agonists | NMBR, NMUR1, NMUR2 | AKR1B1 3142/4885ALDH1A1 4489/4885KDM4E 4831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.